688366 昊海生科
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,710,441-9.93%2,472,9982,697,6582,654,0392,130,276
减:营业总成本1,557,823-2.69%2,136,2742,243,9492,187,7431,864,420
    其中:营业成本588,1764.59%738,762812,626782,849660,761
               财务费用(17,978)-61.24%(60,671)(48,703)(62,217)(74,097)
               资产减值损失(21,104)48.75%(198,518)(32,238)(6,741)(54,239)
公允价值变动收益(85)-157.15%31,06225,9152,296(7,784)
投资收益(404)532.79%4,5421,0021,1425,808
    其中:对联营企业和合营企业的投资收益(404)317.37%109864563,505
营业利润187,618-42.43%220,210494,761507,413234,586
利润总额187,665-45.68%239,245466,145508,261235,727
减:所得税费用27,223-46.65%30,92489,90295,99145,395
净利润160,442-45.52%208,321376,243412,269190,332
减:非控股权益(2,461)-75.82%(42,687)(44,204)(3,852)9,862
股东净利润162,903-46.53%251,009420,447416,121180,470

市场价值指针
每股收益 (元) *0.710-45.80%1.0801.8001.7501.040
每股派息 (元) *0.250-37.50%1.0001.0001.0000.400
每股净资产 (元) *22.992-4.78%23.51623.90832.94931.670
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容